Safety and eficacy of fenofibrate for the treatment of dyslipdemia in AIDS (2002)
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress. Unidades: FM, HU
Subjects: SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, CORAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARAMELLI, B. et al. Safety and eficacy of fenofibrate for the treatment of dyslipdemia in AIDS. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 30 set. 2024. , 2002APA
Caramelli, B., Bernoche, C. Y. S. M. D., Sartori, A. M. C., Strabelli, T. M. V., Monachini, M., Santos, R., & Uip, D. (2002). Safety and eficacy of fenofibrate for the treatment of dyslipdemia in AIDS. Atherosclerosis. Amsterdam: Faculdade de Medicina, Universidade de São Paulo.NLM
Caramelli B, Bernoche CYSMD, Sartori AMC, Strabelli TMV, Monachini M, Santos R, Uip D. Safety and eficacy of fenofibrate for the treatment of dyslipdemia in AIDS. Atherosclerosis. 2002 ; 3 82.[citado 2024 set. 30 ]Vancouver
Caramelli B, Bernoche CYSMD, Sartori AMC, Strabelli TMV, Monachini M, Santos R, Uip D. Safety and eficacy of fenofibrate for the treatment of dyslipdemia in AIDS. Atherosclerosis. 2002 ; 3 82.[citado 2024 set. 30 ]